Clasp Therapeutics Inc

Clasp Therapeutics Inc, based in Rockville, MD, is dedicated to transforming cancer treatment through the development of next-generation T cell engagers that harness the power of precision immunotherapy. The company aims to expand the reach of immuno-oncology by targeting hard-to-treat tumors with common driver mutations, offering hope to patients whose cancers do not respond to current therapies.

With a focus on creating modular, patient-specific treatments, Clasp employs innovative approaches to precisely target cancer-specific markers for destruction. Their commitment to translating cutting-edge research into meaningful medicines is driven by a team of experienced professionals and a collaborative environment that fosters scientific advancement.

Generated from the website